Expansion into cloud services Charles River Laboratories launched Apollo for CRADL, a secure cloud-based platform to enhance vivarium rental services, presenting an opportunity to offer additional tech solutions to clients in the biotech industry.

Global biotech Incubator Program The introduction of Charles River's global biotech Incubator Program opens doors for collaboration and partnerships with startups and emerging biotech companies, providing an avenue for sales of services and resources.

Unique Non-Human Protein Library With the launch of Retrogenix Non-Human Protein Library, Charles River offers a unique resource that can attract biopharmaceutical companies looking for specialized research tools, creating a potential sales opportunity in the niche market segment.

Talent acquisition strategy The recent appointment of Rob Stachlewitz, who joined Resolian after serving as Corporate VP and General Manager at Charles River, indicates a talent pool connection that could present networking opportunities for business development and sales engagements.

Financial resilience amidst restructurings Despite recent layoffs and office closures, Charles River Laboratories' solid financial standing with $1B+ revenue and strategic funding of $1.3M suggests stability and potential investments in innovative solutions, offering a favorable environment for sales initiatives.